再鼎醫藥
09688----
全部股東
股東類型
- 機構投資者62.46%
- 公眾及其他24.04%
- 對沖基金5.86%
- 創投/私募5.47%
- 個人與內幕人士2.18%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
RTW Investments, LP | 5.86% | 657.40 萬 | 0.02% | +0 | 30/06/2026 |
TCG Crossover Management, LLC | 5.47% | 613.76 萬 | -- | +613.76 萬 | 30/06/2026 |
FMR LLC | 4.63% | 520.30 萬 | 0.47% | -52.78 萬 | |
Qiming Weichuang Venture Capital Management (Shanghai) Company Limited | 4.35% | 488.84 萬 | 0.02% | +0 | 31/12/2025 |
RA Capital Management, L.P. | 4.21% | 472.35 萬 | 0.91% | -102.00 萬 | 13/08/2026 |
The Goldman Sachs Group, Inc. | 4.19% | 470.30 萬 | 0.53% | -59.76 萬 | 20/10/2026 |
Vanguard Capital Management, LLC | 3.71% | 416.24 萬 | 0.14% | -16.12 萬 | 30/09/2026 |
ADAR1 Capital Management, LLC | 3.00% | 336.90 萬 | 1.74% | +194.37 萬 | 30/06/2026 |
China Universal Asset Management Company Ltd. | 2.90% | 326.03 萬 | <0.01% | -845.00 | 30/06/2026 |
Wellington Management Group LLP | 2.75% | 309.28 萬 | <0.01% | +0 | 31/12/2025 |
Norges Bank Investment Management | 2.65% | 297.57 萬 | 0.78% | -89.23 萬 | 30/06/2026 |
JPMorgan Chase & Co. | 2.33% | 261.60 萬 | 1.38% | +154.88 萬 | 19/10/2026 |
BlackRock, Inc. | 2.32% | 260.49 萬 | 0.01% | +1.24 萬 | 30/09/2026 |
Woodline Partners LP | 1.97% | 220.73 萬 | 1.97% | +220.73 萬 | 30/06/2026 |
GF Fund Management Co., Ltd. | 1.71% | 192.52 萬 | <0.01% | +64.00 | 30/09/2026 |
Frazier Life Sciences Management, LP | 1.69% | 190.23 萬 | <0.01% | +0 | 30/06/2026 |
Baron Capital Group, Inc. | 1.46% | 163.59 萬 | 0.01% | -2.25 萬 | 30/06/2026 |
Two Sigma Investments, LP | 1.16% | 129.94 萬 | 0.88% | +98.97 萬 | 30/06/2026 |
Citadel Advisors LLC | 1.14% | 128.47 萬 | 0.35% | -40.39 萬 | 30/06/2026 |
Ying DuFounder, Chairperson & CEO | 1.09% | 122.14 萬 | 0.02% | +1.76 萬 |